Meningococcal infection in children: factors influencing outcome

Meningococcal infection in children: factors influencing outcome

Generalized forms of meningococcal infection are characterized by high risk of complication and fatal outcomes. In Russian Federation, 2016, meningococcal infection was the second most common cause of pediatric deaths (25%) due to infectious diseases after community associated-pneumonia. Mandatory v...

Full description

Bibliographic Details
Main Authors:	O. V. Samodova, E. A. Krieger, L. V. Titova, O. Yu. Leonteva
Format:	Article
Language:	Russian
Published:	Journal Infectology 2019-10-01
Series:	Журнал инфектологии
Subjects:	meningococcal infection children outcomes vaccination
Online Access:	https://journal.niidi.ru/jofin/article/view/926

Similar Items

Systemic meningococcal disease in children: survival analysis, Arkhangelsk region, Northwest Russia, 1991–2011
by: O. V. Samodova, et al.
Published: (2014-09-01)

Systemic meningococcal infection in children of the Arkhangelsk region: predictors of unfavorable course and outcome during different periods of observation
by: O. V. Samodova, et al.
Published: (2024-09-01)

Meningococcal infection in children in the period 2012–2021. Main results of a retrospective multicenter study, issues of the day
by: A. A. Vilnits, et al.
Published: (2024-01-01)

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Meningococcal Infection in Children in the Krasnoyarsk Territory: Analysis of Fatal Outcomes
by: G. P. Martynova, et al.
Published: (2015-10-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

CLINICAL-EPIDEMIOLOGICAL FEATURES AND OUTCOME OF GENERALIZED FORMS OF MENINGOCOCCAL INFECTION IN CHILDREN
by: G. P. Martynova, et al.
Published: (2017-10-01)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

PREVENTION OF MENINGOCOCCAL INFECTION
by: I. V. FRIDMAN, et al.
Published: (2017-05-01)

Meningococcal infection is a deadly disease: causes of death in children
by: G. P. Martynova, et al.
Published: (2024-09-01)

Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees
by: Young Rong Kim, et al.
Published: (2024-09-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Vaccines against Meningococcal Diseases
by: Mariagrazia Pizza, et al.
Published: (2020-10-01)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01)

Unusual course of meningococcal infection with lethal outcome (brief communication)
by: V. A. Zinserling, et al.
Published: (2023-07-01)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
by: Jessica Presa, et al.
Published: (2023-01-01)

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination
by: Cynthia Burman, et al.
Published: (2019-02-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)

MENINGOCOCCAL INFECTION IN CHILDREN IN KIROV REGION
by: T. V. Egorova, et al.
Published: (2015-08-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

Herd Protection against Meningococcal Disease through Vaccination
by: Stephen A. Clark, et al.
Published: (2020-10-01)

Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01)

Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico: A Need for Vaccination
by: Enrique Chacon-Cruz, et al.
Published: (2023-02-01)

Antibody persistence following meningococcal C conjugate vaccination in children and adolescents infected with human immunodeficiency virus
by: Ana Cristina Cisne Frota, et al.
Published: (2017-09-01)

Public health management of invasive meningococcal disease outbreaks: worldwide 1973–2018, a systematic review
by: Brianna R. Morello, et al.
Published: (2024-08-01)

Risk Analysis by Age on the Burden of Meningococcal Disease in Spain
by: Irene Rivero-Calle, et al.
Published: (2022-04-01)

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)

Current safety issues with quadrivalent meningococcal conjugate vaccines
by: Tanya R. Myers, et al.
Published: (2018-05-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

Recommendations of the Polish Paediatric Society, the Polish Society of Vaccinology, and the Polish Society of Family Medicine on meningococcal vaccinations in children and adults in Poland
by: Ernest Kuchar, et al.
Published: (2022-12-01)

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
by: Franco M. Piazza, et al.
Published: (2022-01-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Current status and challenges of meningococcal vaccines development in China
by: Ying-hua XU, et al.
Published: (2022-07-01)

Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV
by: Arantxa Berzosa, et al.
Published: (2023-12-01)